COVID-19 vaccine makers should license technology to overcome 'grotesque' inequity: WHO

Middle East
22-03-2021 | 14:32
High views
Share
LBCI
Share
LBCI
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
COVID-19 vaccine makers should license technology to overcome 'grotesque' inequity: WHO
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
2min
COVID-19 vaccine makers should license technology to overcome 'grotesque' inequity: WHO
More producers of COVID-19 vaccines should follow the example of AstraZeneca and license their technology to other manufacturers, the head of the World Health Organization (WHO) said on Monday, as he described vaccine inequity as "grotesque".

WHO Director-General Tedros Adhanom Ghebreyesus noted that the drugmaker said earlier that interim data from trials found the vaccine, developed in conjunction with Oxford University, was 79% effective in preventing symptomatic COVID-19 and, crucially, posed no increased risk of blood clots.

"This data is further evidence that the AstraZeneca vaccine is safe and effective," Tedros told a news conference. WHO chief scientist Soumya Swaminathan called it a "very good vaccine for all age groups".

WHO officials said that there was no sign of falling demand for the AstraZeneca shot through its COVAX vaccine-sharing program after some countries temporarily paused its use over health concerns.

"They did ask a lot of questions but the demand for the vaccine is extremely high," said WHO senior adviser Bruce Aylward. He added, however, that COVAX was having some "teething problems" since manufacturers might not be able to keep up with their roll-out program.
 
 
 
 
REUTERS

Breaking Headlines

Covid-19

Vaccine

WHO

Download now the LBCI mobile app
To see the latest news, the latest daily programs in Lebanon and the world
Google Play
App Store
We use
cookies
We use cookies to make
your experience on this
website better.
Accept
Learn More